Data / Drug companies / Vitamin D3 Analog
Vitamin D3 Analog drugs: 5 drugs from 30 companies in the FDA NDC directory
Vitamin D3 Analog is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 53 products in this class from 30 companies, covering 5 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 15, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 30Companies
- 53Products
- 5Drugs by generic name
Drugs in the Vitamin D3 Analog class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Calcitriol | 36 | 23 |
| Paricalcitol | 9 | 13 |
| Calcitriol capsules 0.25 mcg | 5 | 5 |
| Calcifediol | 2 | 1 |
| Calcitriol capsules 0.5 mcg | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Aphena Pharma Solutions - Tennessee, LLC | 3 | capsule; capsule, liquid filled | Generic drugs (ANDA) | December 10, 2016 |
| Bryant Ranch Prepack | 3 | capsule, liquid filled; capsule | Generic drugs (ANDA) | August 25, 2016 |
| Dr. Reddy's Laboratories Limited | 3 | capsule, liquid filled | Generic drugs (ANDA) | June 25, 2014 |
| Hikma Pharmaceuticals USA Inc. | 3 | injection | New drug applications (NDA) | November 18, 2014 |
| Marksans Pharma Limited | 3 | capsule, liquid filled | Generic drugs (ANDA) | December 31, 2016 |
| A-S Medication Solutions | 2 | capsule, liquid filled; capsule | Generic drugs (ANDA) | June 12, 2018 |
| Amneal Pharmaceuticals LLC | 2 | capsule | Generic drugs (ANDA) | June 18, 2017 |
| Bionpharma Inc. | 2 | capsule, liquid filled | Generic drugs (ANDA) | June 12, 2018 |
| Bryant Ranch Prepack | 2 | capsule, liquid filled | Generic drugs (ANDA) | June 12, 2018 |
| Chartwell RX, LLC | 2 | capsule | Generic drugs (ANDA) | May 29, 2018 |
| Epic Pharma, LLC | 2 | capsule | Generic drugs (ANDA) | February 27, 2026 |
| Golden State Medical Supply, Inc. | 2 | capsule, liquid filled | Generic drugs (ANDA) | May 24, 2013 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 2 | capsule | Generic drugs (ANDA) | May 29, 2018 |
| Hikma Pharmaceuticals USA Inc. | 2 | solution; capsule | Generic drugs (ANDA) | March 27, 2006 |
| Opko Pharmaceuticals, LLC | 2 | capsule, extended release | New drug applications (NDA) | March 11, 2024 |
| Strides Pharma Science Limited | 2 | capsule | Generic drugs (ANDA) | December 27, 2016 |
| Sun Pharmaceutical Industries, Inc. | 2 | capsule, liquid filled | Generic drugs (ANDA) | May 1, 2020 |
| Teva Pharmaceuticals USA, Inc. | 2 | capsule, liquid filled | Generic drugs (ANDA) | August 25, 2016 |
| American Health Packaging | 1 | capsule | Generic drugs (ANDA) | January 23, 2019 |
| Ani Pharmaceuticals, Inc. | 1 | solution | New drug applications (NDA) | May 13, 2026 |
| Bryant Ranch Prepack | 1 | capsule, liquid filled | Generic drugs (ANDA) | May 12, 2025 |
| Cardinal Health 107, LLC | 1 | capsule | Generic drugs (ANDA) | January 23, 2019 |
| Fosun Pharma USA Inc. | 1 | injection | Generic drugs (ANDA) | June 20, 2023 |
| Galderma Laboratories, L.P. | 1 | ointment | New drug applications (NDA) | February 1, 2009 |
| Gland Pharma Limited | 1 | injection | Generic drugs (ANDA) | February 3, 2020 |
| PD-Rx Pharmaceuticals, Inc. | 1 | capsule | Generic drugs (ANDA) | March 27, 2006 |
| Padagis Israel Pharmaceuticals Ltd | 1 | ointment | Authorized generics (NDA) | March 8, 2012 |
| Patrin Pharma, Inc. | 1 | solution | Generic drugs (ANDA) | August 14, 2023 |
| Remedyrepack Inc. | 1 | capsule, liquid filled | Generic drugs (ANDA) | October 15, 2026 |
| Rising Pharma Holdings, Inc. | 1 | solution | Generic drugs (ANDA) | March 21, 2017 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, liquid filled | 22 | 41.5% |
| Capsule | 18 | 34% |
| Injection | 5 | 9.4% |
| Solution | 4 | 7.5% |
| Ointment | 2 | 3.8% |
| Capsule, extended release | 2 | 3.8% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.